In 2012, at the London Summit on Family Planning, a partnership of the Bill and Melinda Gates Foundation, Pfizer, the US Agency for International Development, the UK Department for International Development, the UN Fund for Population Activities and nonprofit PATH announced an initiative to reach 3 million women in sub-Saharan Africa and South Asia over the next three-year period with 12 million doses of a new subcutaneous delivery form of Depo-Provera called Sayana Press. Since that time, it‘s been full speed ahead on Depo-Provera, with the Gates foundation at the helm.